Relationship between stroke etiology and collateral status in anterior circulation large vessel occlusion

Eva Hassler1, Markus Kneihsl2, Hannes Deutschmann1

  • 1Division of Neuroradiology, Vascular and Interventional Radiology, Department of Radiology, Medical University of Graz, Graz, Austria.

Journal of Neurology
|June 27, 2020
PubMed

Insights

Patients with carotid artery stenosis (CAS) have better collateral status for large vessel occlusion (LVO) stroke treated with mechanical thrombectomy (MT). However, outcomes were similar, potentially due to increased adverse events in the CAS group.

Area of Science:

  • Neurology
  • Vascular Medicine
  • Interventional Neuroradiology

Background:

  • Intracerebral collateral status significantly impacts clinical outcomes following mechanical thrombectomy (MT) for large vessel occlusion (LVO) stroke.
  • Preexisting extracranial carotid artery stenosis (CAS) may influence collateral circulation in LVO stroke patients.

Purpose of the Study:

  • To test the hypothesis that patients with ipsilateral CAS exhibit superior collateral status compared to non-CAS patients.
  • To evaluate MT-related adverse events and functional outcomes in both CAS and non-CAS groups.

Main Methods:

  • A 7-year retrospective study of anterior circulation LVO stroke patients undergoing MT.
  • Patients were categorized into CAS (≥50% stenosis) and non-CAS groups.
  • Collateral status was assessed using the Tan Score; functional outcome and adverse events were evaluated at 90 days.

Main Results:

  • 46.4% of LVO stroke patients had CAS (≥50% stenosis).
  • CAS patients demonstrated significantly better collateral status (76.1% vs. 46.0%) and were independent predictors (OR: 3.3, p=0.002).
  • Recanalization rates were similar; however, CAS patients experienced more adverse events (19.6% vs. 6.4%).

Conclusions:

  • Preexisting CAS (≥50%) is associated with enhanced collateral status in LVO stroke patients undergoing MT.
  • Despite better collaterals, functional 90-day outcomes were not significantly different between groups.
  • Higher rates of adverse events in the CAS group may offset the benefits of improved collateral status.
Abstract